Abstract:The microbiota–gut–brain axis plays an important role in the development of Alzheimer's disease (AD). In terms of treatment, it has been proven that traditional Chinese medicine are effective in AD by regulating the gut microbiota. And then gut microbiota and its metabolism may inhibit inflammatory response through tumor necrosis factor‐α (TNF‐α), interleukin (IL), the nuclear factor kappa‐B pathway, and superoxide dismutase metabolism. The sedimentation of β‐amyloid (Aβ) and learning and memory function of AD are finally influenced. It indicates that choosing appropriate Chinese medicine as the complementary treatment may be a better way to achieve satisfactory clinical efficacy in AD. Alzheimer's disease (AD) is caused by a variety of factors, and one of the most important factors is gut microbiota dysbiosis. An imbalance in the gut mincrobiota have been shown to change the concentrations of lipopolysaccharide and short‐chain fatty acids. These microorganisms synthesize substances that can influence the levels of a variety of metabolites and cause multiple diseases through the immune response, fatty acid metabolism, and amino acid metabolism pathways. Furthermore, these metabolic changes promote the formation of β‐amyloid plaques and neurofibrillary tangles. Thus, the microbiota–gut–brain axis plays an important role in AD development. In addition to traditional therapeutic drugs such as donepezil and memantine, traditional Chinese medicines (TCMs) have also showed to significantly decrease the severity of AD symptoms and suppress the underlying related mechanisms. We searched for studies on the effects of different herbal monomers, single herbs, and polyherbal formulas on the gut microbiota of AD patients and identified the relevant pathways through which the gut microbiota affected AD. We conclude that improvements in the gut microbiota not only decrease the occurrence of inflammatory reactions but also reduce the deposition of central pathological products. Herbal monomers have a stronger effect on improving of central pathology. Polyherbal formulas have the most extensive effect on the gut microbiota in patients with AD. Among the effects of formulas, the anti‐inflammatory effect is the most essential and is also the main concern regarding the use of TCMs in treating AD from the viewpoint of the gut microbiota. We hope that this review will be helpful for providing new ideas for the clinical application of TCMs in the treatment of AD.

Role of traditional Chinese medicine in age-related macular degeneration: exploring the gut microbiota's influence

Potential application of traditional Chinese medicine in age-related macular degeneration—focusing on mitophagy

Bioinformatical and Biochemical Analyses on the Protective Role of Traditional Chinese Medicine against Age-Related Macular Degeneration

Non-neglectable therapeutic options for age-related macular degeneration: A promising perspective from traditional Chinese medicine

The Emerging Role of Gut Microbiota in Age-Related Macular Degeneration

Alterations of the intestinal microbiota in age-related macular degeneration

Enhancing Clinical Efficacy Through the Gut Microbiota: A New Field of Traditional Chinese Medicine

Metagenomic Sequencing Analysis Identifies Cross-Cohort Gut Microbial Signatures Associated With Age-Related Macular Degeneration

Exploring the Effect of the Gut Microbiome on the Risk of Age-Related Macular Degeneration from the Perspective of Causality.

The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut–Retina Axis

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease

The Role of the Microbiome in Age-Related Macular Degeneration: A Review of the Literature

Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota–gut–brain axis

The gut-eye axis: from brain neurodegenerative diseases to age-related macular degeneration

Causal Effects of Gut Microbiota on Age-Related Macular Degeneration: A Mendelian Randomization Study

Investigating the causal link between gut microbiota and dry age-related macular degeneration: a bidirectional Mendelian randomization study

Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine

Autophagy Dysfunction, Cellular Senescence, and Abnormal Immune-Inflammatory Responses in AMD: From Mechanisms to Therapeutic Potential

Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration

[The immunomodulatory role of retinal microglial cells in age-related macular degeneration]